Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2029

Annual patent cliff calendar for 2029 — US pharmaceutical patents by expiration date.

Patents
713

Quick answer

713 indexed pharmaceutical patents have expiration dates in 2029. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7585879

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7585852

    Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation

    Solidago AG · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7585877

    Aminophenyl derivatives as selective androgen receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7585622

    Increasing the proliferative capacity of cells using telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7585841

    Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7585653

    Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

    Theravance, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7585667

    Negative strand RNA virus replicon

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7585520

    Compositions containing both sedative and non-sedative antihistamines and sleep aids

    Collegium Pharmaceutical, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7585883

    Substituted pyridines and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7585844

    Myosin light chain kinase inhibitors and methods of use

    University College Cardiff Consultants Limited · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7585842

    Human kunitz-type inhibitor with enhanced antifibrinolytic activity

    The Regents of the University of California · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7585880

    Phenylpropanoic acid derivatives

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7585868

    Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists

    The Regents of the University of California · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7589157

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7588912

    Compositions and methods for preventing and treating anthrax diseases

    The Regents of the University of California · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7588703

    Microencapsulation system and method

    United States of America as represented by the Administrator of NASA · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7589214

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7589100

    Non-hygroscopic and powdery amorphous pimecrolimus

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7589075

    Use of an adenosine A3 receptor agonist for inhibition of viral replication

    CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7589220

    Inhibitors of the anandamide transporter

    UNIVERSITY OF CONNECTICUT · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7589200

    5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7589181

    Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7592016

    Methods for preparing and using implantable substance delivery devices

    The Regents of the University of California · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7592368

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7592453

    Fused quinoline derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7592343

    Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7592340

    Quinoxalines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7592355

    Quinolinone-carboxamide compounds as 5-HT, receptor agonists

    Theravance, Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7592322

    RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7591995

    Cobalamin conjugates useful as imaging and therapeutic agents

    Regents of the University of Minnesota · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 2009239858

    THERAPEUTIC AMIDES

    ALLERGAN INC [US] · Granted Thu Sep 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7595431

    Mouse models of human prostate cancer

    The Regents of the University of California · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7595191

    Isolation and purification of P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7595060

    Yeast-antigen compositions methods of making the same

    The Regents of the University of Colorado · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7595326

    Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs

    Champions Biotechnology, Inc · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7595047

    Compositions and methods for promoting or inhibiting angiogenesis

    Northwestern University · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7595333

    Agent for improving acidosis

    Takeda Pharmaceutical Company Limited · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. AU 2008353468

    Solid forms comprising (+)-2- [1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl] -4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

    CELGENE CORP [CH] · Granted Thu Oct 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7598077

    Compositions and methods for enhancing differential expression

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7598225

    Generation of immune response to prostate-specific antigen (PSA)

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7598277

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7598341

    Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs

    The Regents of the University of California · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7598420

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7598048

    Screening methods for identifying agents that modulate output of a circadian pacemaker

    The Regents of the University of California · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7598280

    Heterocyclic compounds, compositions comprising them and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7598245

    Aminotriazole compounds useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7598338

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7598356

    Method for purifying a protein of the cystine-knot superfamily

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2029?

713 published patents in our USPTO index have expiration dates falling in calendar year 2029.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.